Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheney

Showing results (1561-1570 of 1,634) with videos related to

Pageof 164
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldDominique Potin, Michele Launay, Eric Nicolai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Iscience|December 10, 2020
Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in GlioblastomaRajappa S Kenchappa, Panagiotis Mistriotis, Emily Wisniewski, et al.
Mbio|April 23, 2025
<i>Ex vivo</i> and <i>in vivo</i> HIV-1 latency reversal by "Mukungulu," a protein kinase C-activating African medicinal plant extractKhumoekae Richard, Zhe Yuan, Hsin-Yao Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 20, 2019
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohortErik Thunnissen, Keith M Kerr, Urania Dafni, et al.
Clinical Chemistry|July 14, 2023
Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn ScreeningBennett Oh Vic Shum, Carel Jacobus Pretorius, Letitia Min Fen Sng, et al.
Annals of Family Medicine|November 9, 2021
Improving Suicide Risk Screening to Identify the Highest Risk Patients: Results From the PRImary Care Screening Methods (PRISM) StudyCraig J Bryan, Michael H Allen, Cynthia J Thomsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activityKevin R Guertin, Charles J Gardner, Scott I Klein, et al.
Pageof 164

Showing results (1561-1570 of 1,634) with videos related to

Sort By:
Pageof 164
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldDominique Potin, Michele Launay, Eric Nicolai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffoldScott A Bolton, James C Sutton, Rushith Anumula, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Iscience|December 10, 2020
Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in GlioblastomaRajappa S Kenchappa, Panagiotis Mistriotis, Emily Wisniewski, et al.
Mbio|April 23, 2025
<i>Ex vivo</i> and <i>in vivo</i> HIV-1 latency reversal by "Mukungulu," a protein kinase C-activating African medicinal plant extractKhumoekae Richard, Zhe Yuan, Hsin-Yao Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 20, 2019
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohortErik Thunnissen, Keith M Kerr, Urania Dafni, et al.
Clinical Chemistry|July 14, 2023
Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn ScreeningBennett Oh Vic Shum, Carel Jacobus Pretorius, Letitia Min Fen Sng, et al.
Annals of Family Medicine|November 9, 2021
Improving Suicide Risk Screening to Identify the Highest Risk Patients: Results From the PRImary Care Screening Methods (PRISM) StudyCraig J Bryan, Michael H Allen, Cynthia J Thomsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activityKevin R Guertin, Charles J Gardner, Scott I Klein, et al.
Pageof 164